Press Releases



Mediclinic Intnl plc - Appointment of Alternate Director

08/04/2016
RNS Number : 5533U
Mediclinic International PLC
08 April 2016
 

Mediclinic International plc (the "Company")
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

 

8 April 2016

 

 

Appointment of Alternate Director

 

The Board of Mediclinic International plc is pleased to announce that as of 7 April 2016, Mr Jannie Durand, a non-executive director of the Company, has appointed Mr Pieter Uys as his alternate director.

 

Since 2013, Mr Uys has held the position of Head of Strategic Investment at Remgro Limited, a Johannesburg Stock Exchange listed investment company with meaningful interests in a number of businesses across the world. Prior to joining Remgro, Mr Uys was a founding member and ultimately became the CEO of Vodacom Group, one of the leading mobile networks in Africa. Mr Uys holds a MEng (Electrical) and an MBA from the University of Stellenbosch, South Africa.

 

There is no further information to be disclosed in accordance with Listing Rule 9.6.

 

 

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

 

For further information, please contact:

 

Company Secretary

Victoria Dalby               

Capita Company Secretarial Services Limited

+44 (0)207 954 9528

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSEFIWFMSEEL